fruquintinib
hutchmed
['fruquintinib', 'rectal', 'fresco-2', 'lba25', 'colorectal']
#esmo22 abstract lba25: findings from the global fresco-2 trial show the targeted therapy fruquintinib significantly improved overall survival and progression-free survival in patients with refractory metastatic colorectal cancer: #endcancer
MD Anderson is a global leader in cancer care, research, education and training, and prevention. Appointments available: 1-877-632-6789